<DOC>
	<DOCNO>NCT01376752</DOCNO>
	<brief_summary>CHIPOR hypothesis adjunction platinum HIPEC first relapse epithelial ovarian cancer able improve median OS 12 month . In hypothesis , alpha risk 5 % , power beta 80 % , 3 year period inclusion 3 year follow-up , number patient include 404 . Taking account 10 % failure , overall number 444 patient require .</brief_summary>
	<brief_title>Hyperthermic Intra-Peritoneal Chemotherapy ( HIPEC ) Relapse Ovarian Cancer Treatment</brief_title>
	<detailed_description>The patient receive surgery second line chemotherapy , platinum-based regimen either carboplatine-paclitaxel , carboplatine-caelyx . At end six course IV chemotherapy , disease still respond complete cytoreductive surgery seem possible , patient include sign inform consent operate 5 8 week last second-line chemotherapy cycle . So , surgery patient randomize complete cytoreductive surgery really do receive : - either treatment A = maximal cytoreductive surgery without HIPEC - treatment B = maximal cytoreductive surgery HIPEC The HIPEC do end surgery . At end cytoreductive surgery , tumor residual disease must null limited ( Sugarbaker completeness cytoreduction : CC0 ( residual ) -CC1 ( residual &lt; 0.25cm ) . Two method use HIPEC : Open close abdomen , depend site practice . Each site use method study include patient .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Fever</mesh_term>
	<criteria>Patient age ≥ 18 yr , Performance Status OMS &lt; 2 , Initially treat Epithelial Ovarian Carcinoma Patient peritoneal relapse occur least 6 month initial treatment , resectable without distant metastasis ( exception communicate pleura effusion , sensitive platinebased second line chemotherapy resectable lymphnodes groin retro peritoneal ) Platinum base secondline chemotherapy surgery either carboplatinepaclitaxel , carboplatinecaelyx Complete cytoreductive surgery The surgery plan 5 8 week last 2nd chemotherapy No hepatic failure , bilirubin ≤ 1,5 time Normal limit , ASAT et ALAT ≤ 3 time Upper Normal Limit , No Renal insufficiency ( serum creatinine &lt; 1,5 time normal limit , creatinine clearance &gt; 60 ml/min ) . calculate MDRD method Hematology function : PNN ≥1,5x109/L , platelets ≥ 100x109/L , No contraindication general anaesthesia heavy surgery Patients read , sign date Informed consent study procedure childbearing patient take appropriate contraceptive method treatment 6 month treatment Patient age &lt; 18 year Previous cancer last 5 year ( except cutaneous basocellular epithelioma uterine peripheral epithelioma ) Hypersensitivity Platinum compound Distant metastasis Use antiangiogenic treatment , Patient concurrent severe life threaten disease The need perform two segmental digestive resection CRS +/ HIPEC surgery Any progressive disease IV systemic secondline chemotherapy ( platinebased ) Incomplete cytoreductive surgery macroscopical residual disease ( Sugarbaker &gt; CC1 ) Early relapse : le 6 mois end first treatment . Ovarian tumor Epithelioma Ovarian Cancer Uncontrolled infection , Patients psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule , Clinically significant cardiovascular disease contraindicate hyper hydratation , necessary HIPEC , Patient already treat HIPEC ovarian cancer Individual deprive liberty place authority tutor .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>